Kymera Therapeutics, Inc.
KYMR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$224 | -$147 | -$155 | -$100 |
| Dep. & Amort. | $7 | $4 | $3 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $55 | $43 | $35 | $25 |
| Change in WC | -$24 | $9 | -$38 | -$62 |
| Other Non-Cash | -$9 | -$12 | $1 | $6 |
| Operating Cash Flow | -$195 | -$103 | -$153 | -$129 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$34 | -$3 | -$2 |
| Net Acquisitions | $0 | $0 | -$21 | $6 |
| Inv. Purchases | -$901 | $0 | -$446 | -$456 |
| Inv. Sales/Matur. | $496 | $0 | $469 | $358 |
| Other Inv. Act. | $14 | $174 | $21 | -$6 |
| Investing Cash Flow | -$404 | $140 | $21 | -$100 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2 | -$0 | -$1 | -$1 |
| Stock Issued | $597 | $0 | $150 | $243 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14 | $4 | $4 | $8 |
| Financing Cash Flow | $609 | $4 | $153 | $250 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10 | $41 | $20 | $21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $116 | $75 | $54 | $33 |
| End Cash | $126 | $116 | $75 | $54 |
| Free Cash Flow | -$207 | -$137 | -$156 | -$131 |